Jim Cramer Likes SAIC: 'It's An Inexpensive Stock'

Jim Cramer recommended Science Applications International Corporation (SAIC) as an "inexpensive" buy, despite its shares falling 2.5% following the recent appointment of James Reagan as interim CEO. He also expressed belief in TeraWulf Inc. (WULF), calling it "pure spec," ahead of its November 10 Q3 earnings call, where analysts expect a 5-cent per share loss but project a significant revenue surge to $50.64 billion from $27.06 million year-over-year, as WULF shares gained 3.9%.

Analysis

Jim Cramer expressed a positive outlook on Science Applications International Corporation (SAIC), labeling it an "inexpensive" buy despite its shares declining 2.5% to $91.41 on Monday. This decline followed the October 23 announcement of James Reagan's appointment as interim CEO, succeeding Toni Townes-Whitley. The market's immediate negative reaction contrasts with Cramer's bullish sentiment, suggesting potential investor uncertainty regarding the leadership transition.

Conversely, Cramer also endorsed TeraWulf Inc. (WULF), albeit as a "pure spec" play, ahead of its Q3 earnings call on November 10. Analysts anticipate WULF to report a quarterly loss of 5 cents per share, consistent with the prior year. However, revenue projections are significantly optimistic, forecasting $50.64 billion, a substantial increase from $27.06 million year-over-year.

WULF shares reacted positively, rising 3.9% to $16.10, indicating investor anticipation for the strong revenue growth despite the projected flat earnings per share. The projected revenue figure of $50.64 billion, compared to $27.06 million, suggests an extraordinary growth rate, which could be a key driver for investor interest, though the magnitude warrants careful consideration.

Key Decisions for Investors

• Investors should evaluate SAIC's leadership transition and the market's negative reaction against Jim Cramer's "inexpensive" buy recommendation.
• For TeraWulf (WULF), monitor the upcoming Q3 earnings call closely, focusing on the actual revenue figures and management commentary given the highly optimistic analyst projections and "pure spec" label.
• Consider the significant discrepancy between projected revenue ($50.64 billion) and prior year ($27.06 million) for WULF, and assess the feasibility and implications of such extraordinary growth.